Large-scale testing (Phase 3)Study completedNCT03583372
What this trial is testing
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
Who this might be right for
Overactive Bladder
Urovant Sciences GmbH 506